Hess G, Arnold W, Meyer zum Büschenfelde K H
Antimicrob Agents Chemother. 1981 Jan;19(1):44-50. doi: 10.1128/AAC.19.1.44.
9-beta-D-Arabinofuranosyladenine (ara-A), 1-beta-D-arabinofuranosylcytosine (ara-C), and their 5'-triphosphates (ara-ATP and ara-CTP) were tested for ability to inhibit the hepatitis B virus (HBV)-associated deoxyribonucleic acid (DNA) polymerase. Ara-C did not inhibit the HBV DNA polymerase at the concentrations tested, ara-A did so by 50% at a concentration of 30 mM, with the inhibition noncompetitive with respect to deoxyadenosine 5-triphosphate (dATP). Ara-ATP and ara-CTP inhibited the DNA polymerase test competitively with respect to dATP and dCTP, respectively. Both compounds were also active after initiation of the DNA polymerase reaction. The inhibition caused by ara-ATP and ara-CTP was shown to be reversible, with no evidence that ara-ATP or ara-CTP was incorporated into the HBV DNA.
对9-β-D-阿拉伯呋喃糖基腺嘌呤(ara-A)、1-β-D-阿拉伯呋喃糖基胞嘧啶(ara-C)及其5'-三磷酸酯(ara-ATP和ara-CTP)抑制乙型肝炎病毒(HBV)相关脱氧核糖核酸(DNA)聚合酶的能力进行了测试。在所测试的浓度下,ara-C未抑制HBV DNA聚合酶,ara-A在30 mM浓度下抑制率为50%,对脱氧腺苷5-三磷酸(dATP)而言,该抑制作用为非竞争性。ara-ATP和ara-CTP分别对dATP和dCTP竞争性抑制DNA聚合酶试验。在DNA聚合酶反应开始后,这两种化合物也具有活性。结果表明,ara-ATP和ara-CTP引起的抑制作用是可逆的,没有证据表明ara-ATP或ara-CTP掺入了HBV DNA。